姓名：王玉記

性別：男

職稱：教授

招生院所：澳門新葡官網進入

招生類型：博士研究生、碩士研究生

招生專業：藥物化學（科學學位）藥學（專業學位）

研究方向名稱：抗腫瘤、抗血栓藥物的設計、合成和藥效學研究

電子信箱：ccmuwyj@126.com

個人簡介

博士，教授，澳門新葡官網進入副院長。主要從事抗腫瘤、抗血栓藥物的設計、合成和藥效學研究；其中針對表觀遺傳學靶點-蛋白精氨酸脫亞胺酶4（PAD4）設計并合成的抑制劑的研究文章( J. Biol. Chem., 2012, 287, 25941)他引用90余次，并且被NIH和賓州州立大學等多家學術網站報道: “work in the Journal of Biological Chemistry suggesting that stopping the action of an enzyme called PAD4 (peptidylarginine deiminase 4) sets off a chain reaction of ‘molecular switches’ in cancer cells. The effect is to switch the internal cell signals from growth to death”。根據這樣的設計技術，克服臨床上阿司匹林藥物的缺點，設計并制備了抗血栓小分子納米藥物?；谝陨涎芯?，作為項目負責人獲得科技部863青年科學家項目，國家自然科學基金委面上項目，北京長城學者項目、北京市科技新星，北京市高創計劃“青年拔尖人才”項目等十余項省部級以上項目資助，已發表SCI期刊論文67余篇（IF="228.2），第一作者或責任作者文章16篇（IF" =70.2），作為封面文章1篇，單篇他引次數最高為110余次；共申請中國發明專利340余項，其中111項授權；申請1項美國專利并獲授權；專利轉化一項，合同金額300萬。

在教學方面，每年承擔10余門課程，平均承擔600多學時/年的教學工作，能通講本科生、研究生和留學生等8門課程。一線教學中，“藥物的波譜解析”教學堅持本科生“操作大型儀器”，“藥學技能實驗”教學中堅持“一人一套”實驗模式，“藥物化學”教學中持續教改，留學生和研究生課貫徹課程思政，這些教學實踐提高了本科生和研究生的專業能力以及社會競爭力，獲得了學生和同行的好評，于2014年獲得霍英東青年教師獎三等獎，2018年獲批北京市青年教學名師，2020年“藥物的波譜解析”獲批國家級一流課程（排名第二）；針對藥學實驗中危險實驗，作為第二負責人開發虛擬仿真實驗項目60余項，均獲得軟件著作權，并申請獲批2017年國家級虛擬仿真實驗項目；主講的“實驗室安全培訓”MOOC課程以健康中國和安全生產為目標，在“學堂在線”和“學習強國”在線兩個平臺上線，其中第一次課播放量已經超過83萬次，提高了醫藥從業者和師生的安全意識、規范了安全操作，擴大了首醫影響力；基于以上教育教學工作，共獲得獲澳門新葡官網進入校級教育教學成果一等獎和二等獎各兩次（排名前二）。

教育經歷

1998年8月至2002年6月    北京大學澳門新葡官網進入  藥學         學士

2002年8月至2007年7月      北京大學澳門新葡官網進入  藥物化學        博士

工作經歷

2007-2009      澳門新葡官網進入化學生物學院澳門新葡官網進入，講師

2009-2010      美國賓州州立大學有機化學系、生物化學及分子生物學系，博士后

2010-2011      澳門新葡官網進入化學生物學院澳門新葡官網進入 藥化系副主任/講師

2012-2015      澳門新葡官網進入化學生物學院澳門新葡官網進入 藥化系主任/副教授

2016至今        澳門新葡官網進入化學生物學院澳門新葡官網進入 副院長/教授

重要學術論文：

1. Yu Lu, Di Zhu, Lin Gui, Yuanming Li, Wenjing Wang, Jiawang Liu and Yuji Wang*. A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis by the PARP/ATM pathway. Journal of Nanobiotechnology, 2021, https://doi.org/10.21203/ rs.3.rs-36952/v1 (doi: 10.21203/rs.3.rs-36952/v1).
2. Peng Wang, Lin Gui, Yuji Wang,* Sheng Wang*. In vitro evaluation of a pectin-RGDS-OC8H17-paclitaxel nano-particle coated balloon. Applied Nanoscience, 2021, 11:1339–1347
3. Yu Zhao, Ran Lu, Xin Wang, Xiaochen Huai, Caiyun Wang, Yuji Wang*, Su Chen*. Visible light-induced antibacterial and osteogenic cell proliferation properties of hydrogenated TiO₂ nanotubes/Ti foil composite. Nanotechnology, 2021, 32:195101.
4. Songlin Song, Lin Gui, Qiqi Feng, Ayijiang Taledaohan, Yuanming Li, Wei Wang, Yanming Wang and Yuji Wang*.TAT- modified gold nanoparticles enhance the anti-tumor activity of PAD4 inhibitors. International Journal of Nanomedicine. 2020:15 6659-6671.
5. Xueyuan Chen, Yi Zheng, Songlin Song,Ying Liu, Yi Wang,Yong Huang,Xiaoyi Zhang, Meng Zhang, Ming Zhao, Yuji Wang*, Li Li*.Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Antitumor Agents. J. Org. Chem. 2020, 85, 18, 11618–11625
6. Yuji Wang, Xinyi Xu, Ce Song, Jianhui Wu, Xi Hu, Haimei Zhu, Xiaoyi Zhang, Yaonan Wang, Lin Gui, Ming Zhao, Shiqi Peng. ATIQCTPC targeting MMP-9: A key step to slowing primary tumor growth and inhibiting metastasis of Lewis lung carcinoma in vivo. Oncotarget, 2017, 2017, 8: 63881-63889.
7. Yuji Wang, Jingcheng Tang, Haimei Zhu, Xueyun Jiang, Jiawang Liu, Wenyun Xu, Haiping Ma, Qiqi Feng, Jianhui Wu, Ming Zhao, Shiqi Peng. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. International Journal of Nanomedicine, 2015, 10:6905-6918.
8. Guifeng Kang, Yuji Wang (Co-first author), Jiawang Liu, Jianhui Wu, Ming Zhao, Guochun Li, Ning Li, Li Peng, Xiaoyi Zhang, Li Li, Nathan Mair, Shiqi Peng. Development of three-component conjugates: To get nano-globes with porous surface, high in vivo anti-osteoporosis activity and minimal side effects. Journal of Materials Chemistry, 2012, 22:21740-21748.
9. Yuji Wang, Jianhui Wu, Guifeng Kang, Ming Zhao, Lin Gui, Ning Li, Li Peng, Xiaoyi Zhang, Li Li, Shiqi Peng. Novel nano-materials, RGD-tetrapeptide-modified 17b-amino-11a-hydroxyandrost-1,4- diene-3-one: synthesis, self-assembly based nano-images and in vivo anti-osteoporosis evaluation. Journal of Materials Chemistry, 2012, 22:4652-4659.
10. Yuji Wang, Pingxin Li, Shu Wang, Jing Hu, Xiangyun Amy Chen, Jianhui Wu, Megan Fisher, Kira Oshaben, Na Zhao, Ying Gu, Dong Wang, Gong Chen, Yanming Wang. Anticancer PAD inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex activity. Journal of Biological Chemistry, 2012, 287:25941-25953.
11. Huiliang Zhang, Yuji Wang (Co-first author), Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Lin Gui, Meiqing Zheng, Li Li, Jiawang Liu, Shiqi Peng. Synthesis and In Vivo Lead Detoxification Evaluation of Poly-α,β-DL-aspartyl-L-methionine. Chemical Research in Toxicology, 2012, 25:471-477.
12. Yuji Wang, Kang Guifeng, Liu Jiawang, Zhao Ming, Wu Jianhui, Zhang Xiaoyi, Li Ye, Zhong Xiaobo, Yang Yifan and Peng Shiqi. Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-Pentahydroxylhex-1-yl]-L-amino acid dichloro- platinates (II) with high anti-tumor activity and low side reaction. Metallomics, 2012, 4:441-447.
13. Yuji Wang, Xueyun Jiang, Jiawang Liu, Ming Zhao, Guifeng Kang, Jianhui Wu, Li Peng, Shiqi Peng. HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NO. Molecular BioSystems, 2011, 7:1678-1683.
14. Yuji Wang, Guifeng Kang, Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Yifan Yang, Jiawang Liu, Shiqi Peng. A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin. Molecular BioSystems, 2011, 7:3245-3252.
15. Yuji Wang, Lei Wei, Ming Zhao, Shenghui Mei, Meiqing Zheng, Yifan Yang, Hong Wang, Gong Chen, Shiqi Peng. Development of highly effective three-component cytoprotective adjuncts for cisplatin cancer treatment: synthesis and in vivo evaluation in S180-bearing mice. Metallomics, 2011, 3:1212-1217.
16. Yuji Wang, Lanrong Bi, Baoguang Hou, Yu Chen, Ming Zhao, Chao Wang, Wei Wang, Jingfang Ju, Shiqi Peng. Design and synthesis of pentahydroxylhexylamino acids and their effect on lead decorporation. Chemical Research in Toxicology, 2007, 20:609-615.
17. Haimei Zhu, Yuji Wang, Ce Song, et al. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent. Oncotarget, 2018, 9:268-281.
18. Taiping Gan, Yuji Wang, Ming Zhao, Jianhui Wu, Jian Yang, Shiqi Peng.5-(Bis(3-(2-hydroxyethyl)- 1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHI MHA ): showing a strategy of designing drug to block lung metastasis of tumors.Drug Design, Development and Therapy 2016, 10: 711-721.
19. Wu J , Zhu H , Zhao M ,Wang Yuji, Yang Guodong, Wang Yaonan, Zhaoshuirui, Gui Lin, Peng shiqi. IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo[J]. Journal of Materials Chemistry B, 2016, 5(5):917-927.
20. Xi Hu, Ming Zhao, Yuji Wang, Yaonan Wang, Shurui Zhao, Jianhui Wu, Xiangmin Li and Shiqi Peng.Tetrahydro-b-carboline-3-carboxyl-thymopentin: a nano-conjugate for releasing pharmacophores to treat tumor and complications.J. Mater. Chem. B, 2016:4, 1384-1397.
21. Haimei Zhu, Yuanbo Song, Yuji Wang, Ming Zhao, Yi Ren, Yaonan Wang, Shurui Zhao, Jianhui Wu and Shiqi Peng.Design, synthesis and evaluation of a novel π–π stacking nano-intercalator as an anti-tumor agent. Med. Chem. Commun., 2016, 7, 247-257.
22. Minna Li, Yuji Wang, Yutong Yang, Yeqing Gao, Ming Zhao, Meiqing Zheng, Shiqi Peng。Oximated ruthenium tris-bipyridyl complex: synthesis and luminescent response speci?cally for ClO? in water containing multiple ions. Dalton Trans., 2015, 44: 14071-14076.
23. Jianhui Wu , Haimei Z , Guodong Y , He Jianhong，Wang Yuji，Zhao Shurui，Zhang Xiaoyi，Gui Lin, Zhao Ming, Pengshiqi. Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA. International Journal of Nanomedicine, 2018, 13:1139-1158.
24. Feng Wang, Shan Li, Yuji Wang, Haimei Zhu, Xiaoyi Zhang, Ming Zhao, Jianhui Wu, Shiqi Penga, Enantiomeric diketopiperazines: Getting insight of the impact of the configuration to the conformation, nanoimage, u-PA inhibition and anti-metastatic activity. MedChemComm 2015, 6: 956-962.
25. Wang Xiaozhen, Wang Yuji, Wu Jianhui , et al. Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor[J]. Bioorganic & Medicinal Chemistry Letters, 2017:5114-5118.
26. Fei Gao, Haiqing Liu, Li Li, Jianpeng Guo, Yuji Wang, Ming Zhao, Shiqi Peng. Design, synthesis, and testing of an isoquinoline-3-carboxylic-based novel anti-tumor lead Bioorganic & Medicinal Chemistry Letters, 2015, 25: 4434-4436.
27. Hualong Yu, Shenghui Mei, Li Zhao, Ming Zhao, Yuji Wang, Haimei Zhu, Yaonan Wang, Jianhui Wu, Chunying Cui, Wenyun Xu, Shiqi Peng, RGD-peptides modifying dexamethasone: To enhance the efficacy of anti-inflammation and limit the risk of osteoporosis. Med Chem Comm 2015, 6: 1345-1351.
28. Shan Li, Yuji Wang, Feng Wang, Yaonan Wang, Xiaoyi Zhang, Ming Zhao, Qiqi Feng, Jianhui Wu, Shurui Zhao, Wei Wu, Shiqi Peng, Small molecule PZL318: Forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis. Int J Nanomed, 2015, 10:5273-5292.
29. Shan Li, Yuji Wang, Ming Zhao, Jianhui Wu, Shiqi Peng. BPIC: A novel anti-tumor lead capable of inhibiting inflammation and scavenging free radicals. Bioorg Med Chem Lett. 2015, 25(5):1146-1150
30. Wenhua Zhao, Yuji Wang, Weijia Hao, H Yang, Song X, Ming Zhao, Shiqi Peng. Preparative isolation and purification of urolithins from the intestinal metabolites of pomegranate ellagitannins by high-speed counter-current chromatography.J Chromatogr B Analyt Technol Biomed Life Sci. 2015,990:111-117.
31. Jianhui Wu, Yuji Wang, Yaonan Wang, Ming Zhao, Xiaoyi Zhang, Lin Gui, Shurui Zhao, Haimei Zhu, Jinghua Zhao, Shiqi Peng. Cu2+-RG DFRG DS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy. International Journal of Nanomedicine 2015, 10: 2925-2938.
32. Xueyun Jiang, Yuji Wang, Haimei Zhu, Yaonan Wang, Ming Zhao, Shurui Zhao, Jianhui Wu, Shan Li, Shiqi Peng. Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy. Drug Design, Development and Therapy 2015, 9: 2329-2342.
33. Shuangling Chen, Yuji Wang, Shan Li, Yaonan Wang, Ming Zhao, Haimei Zhu, Jianhui Wu, Shiqi Peng. Poly-α,β-aspartyl-Arg-Gly-Asp-Phe: a novel polymeric nanomedicine. Med. Chem. Commun., 2015, 6:182-186.
34. Wenhua Zhao, Yuji Wang, Weijia Hao, Ming Zhao, Shiqi Peng.In vitro inhibition of fatty acid synthase by 1,2,3,4,6-penta-O-galloyl-β-D-glucose plays a vital role in anti-tumour activity. Biochem Biophys Res Commun. 2014, 445:346-351.
35. Fengxiang Du, Xiaoyi Zhang, Shan Li, Yaonan Wang, Meiqing Zheng, Yuji Wang, Shurui Zhao, Jianhui Wu, Lin Gui, Ming Zhao and Shiqi Peng. Mechanism of forming trimer, self-assembling nano-particle and inhibiting tumor growth of small molecule CIPPCT. Med. Chem. Commun., 2014,5: 1634-1643.
36. Haimei Zhu, Yuji Wang, Yaonan Wang, Shurui Zhao, Ming Zhao, Lin Gui, Wenyun Xu, Xiangyun Amy Chen, Yanming Wang, Shiqi Peng.  Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56. The Journal of Physical Chemistry C, 2013, 117:10070-10078.
37. Haimei Zhu, Yuji Wang, Ming Zhao, Jianhui Wu, Xiaoyi Zhang, Guodong Yang, Shiqi Peng. Energy minimized crystal structures of P-selectins based on molecular dynamics simulation: leading to two average structures capable of designing anti-thrombotic agents. Med. Chem. Commun., 2013, 4:1066-1072.
38. Jiawang Liu, Yuji Wang, Yifan Yang, Xueyun Jiang, Ming Zhao, Wenjing Wang, Guofeng Wu, Jianhui Wu, Meiqing Zheng, Shiqi Peng. Pyrolo[1,2:4,5]-1,4-dioxopyrazino [1,2:1,6]pyrido[3,4-b]indoles: A Group of Urokinase Inhibitors, their Synthesis,and Stereochemistry-Dependent Activity. ChemMedChem, 2011, 6: 2312-2322.
39. Yanxia Xu, Yuji Wang, Ling Wang, Ming Zhao, Xiaoyi Zhang, Xiaomin Hu, Baoguang Hou, Li Peng, Meiqing Zheng, Jianhui Wu, Shiqi Peng. Lead Detoxification Activities of a Class of Novel DMSA-AminoAcid Conjugates. Chemical Research in Toxicology, 2011, 24: 979-984.
40. Yanxia Xu, Yuji Wang, Ming Zhao, Baoguang Hou, Li Peng, Meiqing Zheng, Jianhui Wu, Shiqi Peng. Lead detoxification activities and ADMET hepatotoxicities of a class of novel 5-(1-carbonyl-L-amino-acid)-2,2-dimethyl-[1,3]dithiolane-4-carboxylic acids. Bioorganic Medicinal Chemistry Letters, 2011, 21: 1754-1757.   
41. Yiqing Feng, Yuji Wang, Bradley Landgraf, Shi Liu, Gong Chen. Facile Benzo-Ring Construction via Palladium-Catalyzed Functionalization of Unactivated sp(3) C-H Bonds under Mild Reaction Conditions. Organic Letter, 2010, 12: 3414-3417.
42. Ming Zhao, Yuji Wang, Caixia Huo, Jiawang Liu, Chunyu Li, Xiaoyi Zhang, Li Peng, Shiqi Peng. Lead Detoxification Activity and ADMET Hepatotoxicity of N-(alpha-l-Arabino-furanos-1-yl)-l-cysteine. Chemical Research in Toxicology, 2010, 23: 1282-1285. 
43. Ming Zhao, Yuji Wang, Caixia Huo, Chunyu Li, Xiaoyi Zhang, Li Peng, Shiqi Peng. Stereoselective synthesis of novel N-(a-L-arabinofuranos-1-yl)-L-amino acids. Tetrahedron: Asymmetry, 2009, 20: 20247-20258.
44. Shuangling Chen, Zidong Peng, Yuji Wang, et al. Development and activity evaluation of Arg-Gly-Asp-containing antithrombotic conjugate. Journal of Molecular Structure, 2019, 1198.
45. Lin Gui, Ming Zhao, Yuji Wang, Yinye Wang, Yang Qin, Li Li, Shiqi Peng. Synthesis, nano-features, ex vivo anti-platelet aggregation and in vivo antithrombotic activities of poly-α,β-DL-aspartyl-L-arginine. Medicinal Chemistry Communication, 2012, 3: 102-108.
46. Jingcheng Tang, Ming Zhao, Yuji Wang, Guifeng Kang, Jianhui Wu, Meiqing Zheng, Shiqi Peng. One single HPLC-PDA/(-)ESI-MS/MS analysis to simultaneously determine 30components of the aqueous extract of Rabdosia rubescens. Journal of Chromatography B, 2011, 879: 2783-2793.
47. Wenjing Wang, Ming Zhao, Yuji Wang, Jiawang Liu, Jianhui Wu, Guifeng Kang, Shiqi Peng. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl- ethyl]-1H-indol-3-yl} acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems. Molecular BioSystems, 2011, 7: 766-772.
48. Shaoming Jin, Yaonan Wang, Haimei Zhu, Yuji Wang, Shurui Zhao, Ming Zhao, Jiawang Liu, Jianhui Wu, Wen Gao, Shiqi Peng. Nanosized Aspirin-Arg-Gly-Asp-Val: Delivery of Aspirin to Thrombus by the Target Carrier Arg-Gly-Asp-Val Tetrapeptide. ACS Nano, 2013, 7: 7664-7673.
49. Li Li, Ming Zhao, Wenhao Li, Yuji Wang, Chunna Liu, Zhuge Zhang, Songchun Su,Shiqi Peng. pH-Dependent nanostructure based on isoquinoline-cyclodextrin conjugate for thrombosis therapy. Nanomedicine:NBM, 2012, DOI:10.1016/j.nano.2011.12.008
50. Li Li, Ming Zhao, Wenhao Li, Yuji Wang, Zhuge Zhang, Ran An, Shiqi Peng. Self-complexation and complexation-controlled target cancer therapy. Medicinal Chemistry Communication, 2012, 3: 1059-1061.
51. Li Li, Jianhui Wu, Ming Zhao, Yuji Wang, Huiliang Zhang, Xiaoyi Zhang, Lin Gui, Jiawang Liu, Nathan Mair, Shiqi Peng. Poly-α,β-dl-Aspartyl-l-Cysteine: A Novel Nanomaterial Having a Porous Structure, Special Complexation Capability for Pb(II), and Selectivity of Removing Pb(II). Chemical Research in Toxicology,2012, 25: 1948-1954
52. Chunyu Li, Xiaoyi Zhang, Ming Zhao, Yuji Wang, Jianhui Wu, Jiawang Liu, Meiqing Zheng, Shiqi Peng. A class of novel N-(1-methyl-b-carboline-3-carbonyl)-N’ -(aminoacid-acyl)- hydrazines: Aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis. European Bioorganic Medicinal Chemistry, 2011, 46: 5598-5608.
53. Lu R , Wang C , Wang X ,Wang Yuji, Chen Shu. Effects of hydrogenated TiO2 nanotube arrays on protein adsorption and compatibility with osteoblast-like cells[J]. International Journal of Nanomedicine, 2018, 13:2037-2049.
54. Jianhui Wu, Lei Wei, Ming Zhao, Yuji Wang, Guifeng Kang, Shiqi Peng. N-[2(3-Carboxyl-9-benzyl-carboline-1-yl)ethyl-1-yl]-amino acids: correlation of spectral property with in vivo anti-tumor activity. Medicinal Chemistry Research, 2010, DOI:10.1007/s00044-010-9504-1
55. Li Li, Guohui Cui, Ming Zhao, Yuji Wang, Hong Wang, Wei Li, Shiqi Peng . Assembly of beta-cyclodextrin with 3S-tetrahydro-beta-carboline-3-carboxylic acid and self-assembly of 6-(3'S-carboline-3'-carboxylaminoethylamino)-6-deoxy-β-cyclodextrin. Journal of Physical Chemistry B, 2008, 112: 12139-12147.
56. Kun Yao, Ming Zhao, Xiaoyi Zhang, Yuji Wang, Li Li, Meiqing Zheng, Shiqi Peng. A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-b-carboline-3-carbonyl]- N-(amino-acid-acyl) hydrazine: Discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis. European Journal of Medicinal Chemistry, 2011, 46: 3237-3249.
57. Guodong Yang, Haimei Zhu, Ming Zhao, Jianhui Wu, Yuji Wang, Yanju Wang, Meiqing Zheng, Min Chen, Jiawang Liu, Shiqi Peng. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F) F as an anti-thrombotic agent having dual mechanisms of action. Molecular BioSystems, 2012, 8: 2672-2679.
58. Shenghui Mei, Jiawang Liu, Ming Zhao, Wenjing  Wang, Yuji Wang, Guofeng Wu, Meiqing Zheng, Shiqi Peng. From Cerius2 based stereoview to mouse and enzyme: the model systems for discovery of novel urokinase inhibitors. Molecular BioSystems, 2011, 7: 2664-2669.
59. Jianhui Wu , Chunyu Li, Ming Zhao, Wenjing Wang, Yuji Wang, Shiqi Peng. A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis. Bioorganic & Medicinal Chemistry, 2010, 18: 6220-6229.
60. Hong Wang, Le Peng, Ming Zhao, Jiawang Liu, Xiaoyi Zhang, Yuji Wang, Jianhui Wu, Li Li, Shiqi Peng. 2-Substituted (S)-2-(3,3-dimethyl-1-oxo- 10,10a-dihydroimidazo[1,5-b] isoquinolin-2(1H,3H,5H)-yl) acetic acids: Conformational prediction, synthesis, anti-thrombotic and vasodilative evaluation. Bioorganic & Medicinal Chemistry, 2011, 19: 871-882.
61. Xiaoyi Zhang, Yifan Yang, Ming Zhao, Liu Liu, Meiqing Zheng, Yuji Wang, Jianhui Wu, Shiqi Peng. A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis, European Bioorganic Medicinal Chemistry, 2011, 46: 3410-3419.
62. Meiqing Zheng, Xiaoyi Zhang, Ming Zhao, Heng Wei Chang, Wei Wang, Yuji Wang, Shiqi Peng. (3S)-N-(L-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis. Bioorganic Medicinal Chemistry, 2008, 16: 9574-9587.
63. Jiawang Liu,Shannon Taylor, Patrick Dupart, Corey Arnold, Jayalakshmi Sridhar, Quan Jiang, Yuji Wang, Elena Skripnikova, Ming Zhao, Maryam Foroozesh. Pyranoflavones: A Group of Small-molecule Probes for Exploring the Active Site Cavities of Cytochrome P450 Enzymes 1A1, 1A2, and 1B1. Journal of Medicinal Chemistry, 2013, 56: 4082-4092.
64. Liu Liu, Lei Wei, Yifan Yang, MingZhao, Xiaoyi Zhang, Meiqing Zheng, Yuji Wang, Shiqi Peng. A class of novel AA-Trp-Trp-OBzl: synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and intercalation mechanism. Medicinal Chemistry Communication, 2011, 2: 126-131.
65. Meiqing Zheng, Yifan Yang, Xiaoyi Zhang, Ming Zhao, Jianhui Wu, Gong Chen, Li Peng, Yuji Wang, Peng Shiqi. A class of novel N-isoquinoline-3-carbonyl-l-amino acid benzyl esters: Synthesis, anti-tumor evaluation and 3D QSAR analysis. European Bioorganic Medicinal Chemistry, 2011, 46: 1672-1681.
66. Adharsh P. Ponnapakam, Jiawang Liu, Kaustubh N. Bhinge, Barbara A. Drew, Tony L. Wang, James W. Antoon, Thong T. Nguyen, Patrick S. Dupart, Yuji Wang, Ming Zhao, Yong-Yu Liu, Maryam Foroozesh , Barbara S. Beckmana. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Bioorganic & Medicinal Chemistry, 2014 , 22: 1412-1420.
67. Liu J, Pham PT, Skripnikova EV, Zheng S, Lovings LJ, Yuji Wang, Goyal N, Bellow SM, Mensah LM, Chatters AJ, Bratton MR, Wiese TE, Zhao M, Wang G, Foroozesh M. A Ligand-Based Drug Design, Discovery of 4-Trifluoromethyl-7,8-Pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.J Med Chem. 2015, 58: 6481-6493

承擔重要項目

2018-2020年 北京長城學者項目，小分子PAD4抑制劑抗腫瘤藥物研究，300萬

2015-2018年 科技部863青年科學家項目，小分子抗腫瘤藥物納米制備技術研究，117萬

2015年北京市科技轉化項目，鳥氨酸試劑盒的開發研究，50萬

2015-2018年 北京市高創計劃項目，小分子納米抗腫瘤藥物研究，50萬

2014-2017年年國家自然科學基金面上項目可對接PAD4活性口袋擾亂腫瘤細胞自噬的精氨酸衍生物的構效關系研究，61萬

2013年北京市科技新星項目，新型PAD4抑制劑的合成及抗腫瘤分子機理研究，35萬

2009-2011年國家自然科學基金青年項目N-葡萄糖基-L-氨基酸絡二氯鉑的設計合成與抗腫瘤活性評價，19萬

重要獎項

2018年北京市青年教學名師

2015年北京市高創計劃“青年拔尖人才”

2014年霍英東青年教師獎三等獎

2013年北京市科技新星

2011年北京市教育先鋒號（排名2）